RapidAI is a leading brand in the field of brain imaging analysis, providing healthcare professionals with proven software tools to enhance the identification and diagnosis of cerebrovascular disorders. With a focus on redefining stroke care, RapidAI leverages machine learning technology to deliver Stroke AI, enabling more accurate and efficient diagnosis. Their suite of products includes Rapid NCCT, Rapid ICH, Rapid Hyperdensity, Rapid ASPECTS, Rapid CTA, Rapid LVO, Rapid CTP, and Rapid MRI, designed to cater to various aspects of stroke identification and treatment.

Backed by years of research and validation in clinical trials, RapidAI's solutions have been adopted by healthcare professionals worldwide. The brand takes pride in its team of experienced neurologists, radiologists, technologists, and entrepreneurs who continuously innovate to advance stroke care and save lives. With a global presence and partnerships, RapidAI is committed to enabling faster clinical decision-making and improving patient outcomes in neurovascular and vascular care